New Chemotherapeutic Agents for the Treatment of Non-small Cell Lung Cancer

This publication has 38 references indexed in Scilit:

• Clinical Trials of Irinotecan Hydrochloride (CPT, Campto Injection, Topotecin Injection) in Japan^a
  Annals of the New York Academy of Sciences, 1996
• Promising new agents in the treatment of non-small cell lung cancer
  Cancer Chemotherapy and Pharmacology, 1996
• A Limited Sampling Model for Estimating Pharmacokinetics of CPT‐11 and Its Metabolite SN‐38
  Japanese Journal of Cancer Research, 1995
• A Pharmacokinetic and Pharmacodynamic Analysis of CPT‐11 and Its Active Metabolite SN‐38
  Japanese Journal of Cancer Research, 1995
• 7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trials
  Cancer Chemotherapy and Pharmacology, 1994
• Phase I and pharmacokinetic trial of weekly CPT-11.
  Journal of Clinical Oncology, 1993
• Polychemotherapy in advanced non small cell lung cancer: a meta-analysis
  The Lancet, 1993
• Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line
  Biochemical and Biophysical Research Communications, 1992
• Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.
  Journal of Clinical Oncology, 1990
• Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in mice
  Cancer Chemotherapy and Pharmacology, 1988